Immunophilins, mTOR, and pharmacodynamic strategies for a targeted cancer therapy.
Year: 2003
Type: article
Source: PubMed
Author: Matthew W Harding
Institution: Vertex Pharmaceuticals (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1600034671
